Furthermore, the screening of genetic risk profiles containing CSAG4, PIP4P2, and TOMM5 among dominant bacterial subtypes is capable of being utilized in predicting the clinical prognosis of HCC patients (42). This evidence concerns the gene CSAG4 and hepatocellular carcinoma.